New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
12:17 EDTBBRY, DECK, RPRX, FIVE, UTIW, PVHOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday and if the S&P's level holds into the close, the index will set a new all-time closing record. Equity markets being closed for a holiday tomorrow makes this the last trading day of the quarter, and buyers have emerged to position their portfolios accordingly... ECONOMIC EVENTS: In the U.S., initial jobless claims increased 16K from the prior week to a seasonally adjusted 357K, versus expectations for 340K claims. The Commerce Department upwardly revised its estimate for gross domestic product expansion in the fourth quarter to 0.4% growth from its prior estimate of a 0.1% growth rate. However, this was a bit below the 0.5% gain forecast by analysts. The Chicago PMI Business Barometer Index came in at 52.4, missing the expected reading of 56.5... COMPANY NEWS: Blackberry (BBRY) posted an adjusted profit for its most recent quarter, when a loss was expected, and said it shipped 6M smartphones, including approximately 1M BlackBerry 10 units. The company also reported a gross margin of 40% in the quarter and said its cash position grew to $2.9B. Shares of the mobile device maker gained 2% near noon following the report and associated conference call... MAJOR MOVERS: Among the notable gainers were shares of Repros Therapeutics (RPRX), which rose 71% after the company announced its Androxal drug for the treatment of secondary hypogonadism reached its primary endpoints in a study. Also higher was Deckers Outdoor (DECK), which advanced over 7% after a Jefferies analyst increased his price target on the shares to $100 from $65. Among the noteworthy losers following their earnings reports were Five Below (FIVE), UTi Worldwide (UTIW) and PVH Corp. (PVH), which all fell around 4%... INDICES: Near noon, the Dow was up 43.25, or 0.30%, to 14,569.41; the Nasdaq was up 2.90, or 0.09%, to 3,259.42; and the S&P 500 was up 3.64, or 0.23%, to 1,566.49.
News For BBRY;DECK;RPRX;FIVE;UTIW;PVH From The Last 14 Days
Check below for free stories on BBRY;DECK;RPRX;FIVE;UTIW;PVH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
13:33 EDTPVHGoldman to hold a conference
Subscribe for More Information
August 29, 2014
07:16 EDTRPRXRepros Therapeutics price target raised to $30 on '305 results at BofA/Merrill
Subscribe for More Information
06:23 EDTPVHPVH September volatility elevated into Q2 and outlook
PVH September call option implied volatility is at 30, October is at 26, December is at 24; compared to its 26-week average of 26 according to Track Data, suggesting large near term price movement into the expected release of Q2 on September 4.
August 28, 2014
16:21 EDTRPRXOn The Fly: Closing Wrap
Subscribe for More Information
12:34 EDTRPRXOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday as concern over the Ukraine crisis overshadowed an upward revision to the government's estimate of U.S. economic growth in the second quarter. The major averages began the session in negative territory and picked up downside momentum in early trading, but soon after began to drift off their lows and recapture some of their losses. Volume remains light, as is expected ahead of the upcoming long weekend. ECONOMIC EVENTS: In the U.S., Q2 GDP growth was unexpectedly boosted to 4.2% from the first estimate of 4.0%. Personal consumption rose 2.5% during the second quarter, versus estimates for a 2.4% increase. Initial jobless claims ticked down slightly to 298K in the fourth week of August. Pending home sales index increased 3.3% in July, which was better than the 0.5% month-over-month increase that was expected. In Europe, Ukraine president Poroshenko reportedly accused Russia of a "de facto" invasion and canceled a trip to call an urgent meeting of his security and defense council. COMPANY NEWS: Shares of Visa (V) declined 1% after Raymond James lowered its rating on the credit card giant's stock to Market Perform from Outperform. The Dow component faces a number of headwinds, including tougher negotiating tactics by larger international banks looking to win better deals, lower cross-border volume, and loss of processing revenue in Russia, wrote Raymond James analyst Wayne Johnson. MAJOR MOVERS: Among the notable gainers was Repros Therapeutics (RPRX), which jumped 20% after the first of two identical pivotal studies comparing Androxal to an FDA approved topical gel and placebo achieved superiority in both co-primary endpoints and Piper Jaffray hiked its price target on the stock to $33 from $26. Also higher was Signet Jewelers (SIG), which rose nearly 7% after reporting Q2 results that analysts at Sterne Agee called "impressive." Among the noteworthy losers were a number of retailers who dropped after reporting results from their most recent fiscal quarters. Shares of home goods retailer William-Sonoma (WSM) dropped 11%, jeans maker Guess (GES) fell 9%, and apparel retailer Abercrombie & Fitch (ANF) slipped more than 4%. INDEXES: Near midday, the Dow was down 33.92, or 0.2%, to 17,088.09, the Nasdaq was down 4.52, or 0.1%, to 4,565.11, and the S&P 500 was down 2.04, or 0.1%, to 1,998.08.
11:57 EDTRPRXRepros next Androxal trial should hit endpoints also, says Brean Capital
Subscribe for More Information
11:08 EDTBBRYStocks with call strike movement; QIHU BBRY
Subscribe for More Information
10:25 EDTRPRXHigh option volume stocks
Subscribe for More Information
10:10 EDTRPRXRepros Therapeutics price target raised to $33 from $26 at Piper Jaffray
Subscribe for More Information
08:55 EDTRPRXOn The Fly: Pre-market Movers
HIGHER: Digital Ally (DGLY), up 16% after announcing order from Michigan State Police for over $1.1M... EnteroMedics (ETRM), up 12.4% after reporting three-year data from Maestro RC system... Repros (RPRX), up 0.8% after Androxal achieves superiority in both co-primary endpoints in a study... Synthetic Biologics (SYN), up 2.7% after Pfizer (PFE) was granted FDA Fast Track designation for its investigational Clostridium difficile vaccine candidate. Synthetic Biologics announced earlier this week that SYN-004, the company's lead anti-infective product candidate for the prevention of the effects of C. difficile, will be presented in October... Signet (SIG), up 3.9% after Q2 revenue tops consensus. DOWN AFTER EARNINGS: Abercrombie & Fitch (ANF), down 5.7%... Guess (GES), down 8.3%... Frontline (FRO), down 7%. ALSO LOWER: Williams-Sonoma (WSM), down 10.9% after downgraded at Morgan Stanley following the company's Q2 earnings report... GT Advanced (GTAT), down 2% after downgraded at Raymond James... Sungy Mobile (GOMO), down 20.1% following earnings report, CFO resignation, downgrade of stock at Oppenheimer... Genesco (GCO), down 7.7% after cutting fiscal year forecast.
07:29 EDTRPRXRepros Therapeutics to host conference call
Conference call to discuss Androxal's top line results will be held on August 28 at 9 am. Webcast Link
05:10 EDTRPRXRepros reports Androxal achieves superiority in both co-primary endpoints
Subscribe for More Information
August 26, 2014
11:12 EDTRPRXHigh option volume stocks
Subscribe for More Information
August 25, 2014
07:44 EDTBBRYMobileIron could benefit from BlackBerry replacements, says Deutsche Bank
Subscribe for More Information
August 24, 2014
14:36 EDTBBRYBlackBerry wins another court victory against Typo Products, WSJ says
Subscribe for More Information
August 22, 2014
11:05 EDTRPRXPiper Jaffray biopharm analyst holds an analyst/industry conference call
Subscribe for More Information
09:01 EDTRPRXRepros Therapeutics has favorable near-term catalysts, says BofA/Merrill
BofA/Merrill lowered Repros Therapeutics' price target to $27 from $32 due to competitive pricing and a contraction in the TRT market but says it expects favorable near-term data from Androxal and AndroGel studies. The firm expects the Sept 17 FDA meeting to access DV risks from exogenous testosterone to be favorable. Shares are Buy rated.
August 21, 2014
10:13 EDTFIVEStocks with call strike movement; PBR FIVE
Subscribe for More Information
August 20, 2014
11:50 EDTBBRYStocks with call strike movement; PBR BBRY
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use